The Walton Centre Charity Annual Report and Accounts 2021122 ol •* The Walton Centre Charity Support1119 Ix6ellen¢e
Phy0¢$t Mtya In Oreor patitittgyms
roscic4Gc Young fundTaiserAr¢hwithdad Ad Sam Jrtel cornpletirq lus17 Hope challenge mum nHi
A Healthcare Assithnt prety a ftKX)itorto ith a patienton Chbva55eWard.
| Note | 2021/22 | 2020/21 | ||||
|---|---|---|---|---|---|---|
| Total Funds | Total Funds | |||||
| (Unrestricted) | (Unrestricted) | |||||
| EOOO | E000 | |||||
| Income and endowments | from; | |||||
| Donations and legacies |
257 | 504 | ||||
| Other trading activities |
93 | |||||
| Investments | 30 | 21 | ||||
| Total income and endowments | 380 | 529 | ||||
| Expenditure on: |
||||||
| Raising funds | 244 | 194 | ||||
| Chantable activities |
394 | 491 | ||||
| Total expenditure | 638 | 685 | ||||
| Net gains/(losses) on investments |
86 | 168 | ||||
| Net income/(expenditure) | and net movement | in funds | 6 | (172) | 12 | |
| Reconciliation offunds: |
||||||
| Fund balances brought | forward | 1,561 | 1,850 | |||
| Fund balances carried forward | 1,689 | 1,861 |
| Note | 2021/22 | 2020/21 | ||||
|---|---|---|---|---|---|---|
| Total Funds | Total Funds | |||||
| (Unrestricted) | (Unrestricted) | |||||
| EOOO | EOOO | |||||
| Fixed assets | ||||||
| Investments | 1,248 | 1,162 | ||||
| Totalfixed assets | 1,248 | 1,162 | ||||
| Current assets | ||||||
| Debtors | 80 | |||||
| Cash at bank and | in | hand | 650 | 680 | ||
| Total current assets | 653 | 760 | ||||
| Creditors amounts |
fa((ing | due within one year | 212 | 61 | ||
| Net current assets/(liabilities) | 441 | 699 | ||||
| Total assets less current | liabilities | 1,689 | 1,861 | |||
| Total net assets | 1,689 | 1,861 | ||||
| Funds ofthe Charity | ||||||
| Unrestricted | 10 | 1,689 | 1,861 | |||
| Totalfunds | 1,689 | 1,861 |
| Note | 2021/22 | 2020/21 | |||
|---|---|---|---|---|---|
| Total Funds | Total Funds | ||||
| (Unrestricted) | (Unrestricted) | ||||
| EOOO | E000 | ||||
| Cash flows from operating | activities: | ||||
| Net cash provided by (used in) operating |
activities | (60) | (265) | ||
| Cash flows from investing | activities: | ||||
| Dividends and interest from |
investments | 30 | 21 | ||
| Proceeds from sale of investments | |||||
| Purchase of investments | (27) | ||||
| Net cash provided by (used in) investing |
activities | 30 | (6) | ||
| Change in cash and cash equivalents |
(30) | (271) | |||
| in the reporting penod |
|||||
| Cash and cash equwalents | at the beginning | 680 | 951 | ||
| ofthe reporting penod |
|||||
| Cash and cash equivalents | at the end | 650 | 680 | ||
| ofthe reporting period |
| Reconciliation of |
net income/(expenditure) | to net cash flow from operating | activities: | |
|---|---|---|---|---|
| Net income/(expenditure) for the reporting |
penod | (172) | 12 | |
| (as per the statement of financia activities) |
||||
| Adjustments for: |
||||
| (Gains)/losses on |
investments | (86) | (168) | |
| Dividends and interest from investments |
(30) | (21) | ||
| (Increase)/decrease | in debtors | 77 | (75) | |
| Increase/(decrease) | in creditors | 151 | (14) | |
| Net cash provided | by (used in) operating | activities | (60) | (265) |
| 2021/22 | 2020/21 | ||
|---|---|---|---|
| Total Funds | Total Funds | ||
| (Unrestricted) | (Unrestricted) | ||
| EOOO | EOOO | ||
| Income and | endowments | ||
| Donations | 239 | 409 | |
| I egaoes | 18 | 95 | |
| Fundraising | activities and events | 93 | |
| Investment | income | 30 | 21 |
| Total income and endowments | 380 | 529 |
| 2021/22 | 2020/21 | |||
|---|---|---|---|---|
| Tota I Funds | Total Funds | |||
| (Unrestricted) | (Unrestricted) | |||
| EOOO | EOOO | |||
| Raising Funds: | ||||
| Fundraising | staff costs | 176 | 169 | |
| Fundraising | activities and events | 68 | 25 | |
| 244 | 194 | |||
| Charitable | Activities: | |||
| Patients welfare and amenities | 169 | 199 | ||
| Staff welfare | and amenities | 50 | 158 | |
| Research | 127 | 95 | ||
| Independent | examination | |||
| Administrative | support | 45 | 38 | |
| 394 | 491 | |||
| Total | 638 | 685 |
| 2021/22 | 2020/21 | |||
|---|---|---|---|---|
| Total Funds | Total Funds | |||
| (Unrestricted) | (Unrestricted) | |||
| EOOO | EOOO | |||
| Fundraising | Staff Costs | |||
| Salaries and | wages | 142 | 136 | |
| Sooal security costs | 15 | 15 | ||
| Employers | pension | contribution | 19 | 19 |
| Total Fundraising | Staff Costs | 176 | 170 |
| 2021/22 | 2020/21 | |||||
|---|---|---|---|---|---|---|
| EOOO | EOOO | |||||
| Market value at the beginning of the |
reporting | penod | 1,162 | 967 | ||
| Less Disposals at carrying | value | |||||
| Aqutsittons at cost |
27 | |||||
| Unreaksed gains/(losses) |
86 | 168 | ||||
| Market value at the end | ofthe reporting | period | 1,248 | 1,162 | ||
| Book cost at the end ofthe reporting | period | 1,000 | 1,000 | |||
| All investments are held |
in the UK and the | market value can be analysed | as follows | |||
| 2021/22 | 2020/21 | |||||
| EOOO | EOOO | |||||
| Listed investments | 1,248 | 1,162 | ||||
| Total | 1,248 | 1,162 |
| 2021/22 | 2020/21 | ||||
|---|---|---|---|---|---|
| EOOO | EOOO | ||||
| Prepayments | and | accrued | income | 80 | |
| Total | 80 |
| 2021/22 | 2020/21 | |||
|---|---|---|---|---|
| EOOO | EOOO | |||
| Cash | at bank and | in hand | 650 | 680 |
| Total | cash and cash equivalents | 650 | 680 |
| 2021/22 | 2020/21 | ||||||
|---|---|---|---|---|---|---|---|
| EOOO | EOOO | ||||||
| Amounts | due | to | ~HS | Foundation | Trust | 23 | |
| Accruals | 189 | 61 | |||||
| Total | 212 | 61 |
| Balance as at | Income | Expenditure | Revaluation | of | Balance as at | ||
|---|---|---|---|---|---|---|---|
| 1April 2021 | investments | 31March 2022 | |||||
| EOOO | EOOO | EOOO | EOOO | EOOO | |||
| Unrestricted | Funds | 1,693 | 380 | (638) | 1,435 | ||
| Revaluation | Reserve | 168 | 86 | 254 | |||
| Total | 1,861 | 380 | (638) | 86 | 1,689 |
| Fund | Name | Fund Balance | |||
|---|---|---|---|---|---|
| 2021/22 | 2020/21 | ||||
| EOOO | EOOO | ||||
| 4009 | GeneralFund | 804 | 818 | ||
| 4010 | ~RU Fund | 17 | 20 | ||
| 4015 | Wards Fund | 17 | 18 | ||
| 4017 | Roy Ferguson Compassionate | Care Fund | 70 | 71 | |
| 4019 | Headache and Neurology |
Fund | |||
| 4422 | Pain Relief Research Fund |
||||
| 4442 | Neuro General Research Fund |
||||
| 4457 | Neuro Muscular Diseases |
Fund | |||
| 4464 | Cerebro Vascular Fund |
27 | 28 | ||
| 4465 | Home From Home | 35 | |||
| 4481 | Neurosurgical General Fund |
28 | 32 | ||
| 4487 | Horsley ITU Fund |
76 | 76 | ||
| 4499 | Epilepsy Fund |
27 | 27 | ||
| 4527 | RErD ft Higher Study | 20 | |||
| 4528 | Neurophysiology Train ft |
Educ | |||
| 4530 | Neurological Disability Fund |
65 | 95 | ||
| 4532 | L Loudrey Mvmt Disorders |
Fund | |||
| 4533 | Alan Sutctffe Kerr Lecture | Fund | |||
| 4537 | Cognitive Research Fund |
||||
| 4538 | Stereotactic Fund |
10 | |||
| 4541 | Neurobiochemistry Fund |
||||
| 4543 | Disorders Of Movement Gen Fund |
59 | 60 | ||
| 4550 | Research Fellowship |
||||
| 4552 | Parkinsons Disease |
||||
| 4900 | Neuro X-Ray Research | 16 | 21 | ||
| 4905 | Neurosurgical Neuro-Oncology |
21 | 30 | ||
| 4910 | Brain infections Research |
||||
| 4911 | Nmo And Atypical Disorders |
18 | 18 | ||
| 4915 | The Sid Watkins Innovation |
Fund | 122 | 261 | |
| 1,438 | 1,693 |
| Fund | Fund Name | Fund Manager | Alms and | Obfectives | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4009 | General Fund |
Chief Finance | Officer/Ouorum | of | Any chantable purpose relating toThe Walton Centre |
||||||||||
| Panel | |||||||||||||||
| 4010 | NRLI | ECottier/R Moreton |
Social and | recreational facilities for inpatients, |
improving | ||||||||||
| quality of | fife | ||||||||||||||
| 4015 | Wards Fund | 1Salter /N Martin | Items for wards to benefit patients, carers and staff, | staff | study | ||||||||||
| support | |||||||||||||||
| 4017 | Roy Ferguson Comp Care | Award | L Salter | Annual compassionate care |
pro/ect | ||||||||||
| 4019 | ~eadache And Neurology | Fund | Dr Silver | Research | into headache and |
allied disorders, | support | ||||||||
| presentations | |||||||||||||||
| 4422 | Pai~ Relief Research Fund |
Dr M Gupta/J | Tetlow | Research | and education | ||||||||||
| 4442 | Neuro General Research | Fund | Dr Nicolson | Research | pro/ects relaeng to |
any | aspect ofclinical soence | ||||||||
| 4457 | Neuro Muscular Diseases |
Fund | Dr C Dougan | Research and teaching in the |
field | ofneuromuscular | diseases | ||||||||
| 4464 | Cerebro Vascular Fund |
Dr Nicolson | Research, | education, training |
and | equipment | |||||||||
| 4465 | ~ome From Home | Chief Finance | Officer/Ouorum | of | Maintain the relatives' accommodation |
||||||||||
| Panel | |||||||||||||||
| 4481 | Neurosurgical General |
Fund | Dr 5 Niven | Research, | education, training |
and | equipment | ||||||||
| 4487 | ~orsley ITIJ Fund | Dr Lakhani/M | Rackham | Improve standard ofcare to |
patients and their relatives, | study | |||||||||
| support | |||||||||||||||
| 4499 | Epilepsy Fund |
Dr T Marson | Research | ||||||||||||
| 4527 | RE D8~igher Study | C Chadwick | Research, | education, training |
and | equipment | |||||||||
| 4528 | Neurophysiology Train |
8 | Educ | C Finnegan | Jraining/education for Neurophysiology staf |
||||||||||
| 4530 | Neurological Disability |
Fund | Prof C Young | Research/service development activities in disabling |
|||||||||||
| conditions | |||||||||||||||
| 4533 | Alan Sutcliffe Kerr Lecture | Fund | Chief Finance | Officer | Spews list | research and education |
|||||||||
| 4537 | Cognitive Research Fund |
Dr M Doran | Research | and development | |||||||||||
| 4538 | Stereotactic Fund |
MrJ Farah | Research | and training | |||||||||||
| 4541 | Neurobiochemistry Fund |
C Chadvack/N | Moxham | Research, | education, training |
and | equipment | ||||||||
| 4543 | Disorders Of Movement | Gen Fund | Dr AP Moore | Research, | education, development of new service initiatives |
||||||||||
| 4550 | Neuropsychology Fund |
J Martlew | Research, | patient education | and | equipment | to | ||||||||
| benefit patients | |||||||||||||||
| 4552 | Parkinson's Disease |
Dr M Steiger | Research, | education and training |
|||||||||||
| 4900 | Neuro X-Ray Research | Dr 5 Niven | Advancement of Neuroradiology |
||||||||||||
| 4905 | Neurosurgical Neuro-Oncology |
Mr A Brodbelt/ | Mr M Jenkinson | Research, | education, training |
and | equipment | ||||||||
| 4910 | Brai~ Infections Research | Prof T Solomon | Research | ||||||||||||
| 4911 | Nmo and Atypical Disorders | Dr A Jacob | Research | and patient care | |||||||||||
| 4915 | The Sid Watkins Innovation |
Fund | Chief Finance | Officer/Quorum | of | Support innovation through |
The | Walton Centre | in research, | ||||||
| Panel | prevention, | diagnosis, treatment |
and the overall | care of | |||||||||||
| people with diseases or in/ury of | the nervous | system |
Thank you The Charity is grateful to all our donors and supporters for all they do to raise funds an awareness for The Walton Centre Charity. to help us make a difference to patients an their families both now and in the future. A Nutse with a pawion lhelAYrelUrbth Lipton Ward.
4
Contact us If you would like to contact us about fundraising. events or volunteering please get in touch. Call 0151556 3466 Write The Walton Centre Charity The Walton Centre NHS Foundation Trust Lower Lane, Fazakerley Liverpool L9 7LJ Visit thewaltoncentrecharity.org The Walton Centre Charity SuppDrtl&l9 Ex6¢ll¢n